News for Vectura Group plc (VEGPF)

Collaboration aims to facilitate research and medical affairs initiatives related to medical cannabis in Canada TORONTO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- A

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological...

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo…

Launch represents Vectura Fertin Pharma’s first medical cannabis CBD lozenge to be introduced in Canada Launch follows announcement of commercial...

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration Aurora Cannabis…

Philip Morris International Inc. Glossary of Key Terms, Definitions and Explanatory Notes; and ...

The increasing prevalence of respiratory diseases, the growing patient preference for inhalation therapy, and the advances in inhalation capsule technology...

A comprehensive analysis of Philip Morris International Inc.'s upcoming earnings report, examining its track record. Click for my look ahead at PM's Q4 earnings.

Big Tobacco anticipates a £25 billion ($31.5 billion) charge, acknowledging a grim future for traditional cigarette brands...

/PRNewswire/ -- The "Idiopathic Pulmonary Fibrosis Treatment Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added...

/PRNewswire/ -- The "Global Targeted Drug Delivery Market by Disease Type, Application, End-user, and Region - Size, Share, Outlook, and Opportunity Analysis,...

BOSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) — EnBiotix, Inc. , a rare disease company currently focused on chronic respiratory disorders, today announced the…

Octopus AIM VCT 2 plc 18 August 2021 Portfolio Update The investment portfolio of Octopus AIM VCT 2 plc (the "Company") as at 18 August 2021 is as...

After Brexit, investors think big assets can be found cheaply

Bunzl's Prospects Are Better Than The Market Thinks 1217 GMT - Bunzl is a well-run, attractively priced, acquisitive business where market expectations are too cautious, Berenberg says, raising...